BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36468408)

  • 1. Alcohol-specific inhibition training in patients with alcohol use disorder: a multi-centre, double-blind randomized clinical trial examining drinking outcome and working mechanisms.
    Stein M; Soravia LM; Tschuemperlin RM; Batschelet HM; Jaeger J; Roesner S; Keller A; Gomez Penedo JM; Wiers RW; Moggi F
    Addiction; 2023 Apr; 118(4):646-657. PubMed ID: 36468408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Learning to resist the urge: a double-blind, randomized controlled trial investigating alcohol-specific inhibition training in abstinent patients with alcohol use disorder.
    Tschuemperlin RM; Stein M; Batschelet HM; Moggi F; Soravia LM
    Trials; 2019 Jul; 20(1):402. PubMed ID: 31277683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcoholics Anonymous and other 12-step programs for alcohol use disorder.
    Kelly JF; Humphreys K; Ferri M
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012880. PubMed ID: 32159228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right Inferior Frontal Activation During Alcohol-Specific Inhibition Increases With Craving and Predicts Drinking Outcome in Alcohol Use Disorder.
    Grieder M; Soravia LM; Tschuemperlin RM; Batschelet HM; Federspiel A; Schwab S; Morishima Y; Moggi F; Stein M
    Front Psychiatry; 2022; 13():909992. PubMed ID: 35845462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol-related context modulates neural correlates of inhibitory control in alcohol dependent patients: Preliminary data from an fMRI study using an alcohol-related Go/NoGo-task.
    Stein M; Steiner L; Fey W; Conring F; Rieger K; Federspiel A; Moggi F
    Behav Brain Res; 2021 Feb; 398():112973. PubMed ID: 33157169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol use in the year following approach bias modification during inpatient withdrawal: secondary outcomes from a double-blind, multi-site randomized controlled trial.
    Manning V; Garfield JBB; Reynolds J; Staiger PK; Piercy H; Bonomo Y; Lloyd-Jones M; Jacka D; Wiers RW; Verdejo-Garcia A; Lubman DI
    Addiction; 2022 Nov; 117(11):2837-2846. PubMed ID: 35792053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.
    Bogenschutz MP; Ross S; Bhatt S; Baron T; Forcehimes AA; Laska E; Mennenga SE; O'Donnell K; Owens LT; Podrebarac S; Rotrosen J; Tonigan JS; Worth L
    JAMA Psychiatry; 2022 Oct; 79(10):953-962. PubMed ID: 36001306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial.
    Hauser P; Fuller B; Ho SB; Thuras P; Kern S; Dieperink E
    Addiction; 2017 Jul; 112(7):1173-1183. PubMed ID: 28192622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
    Namkoong K; Lee BO; Lee PG; Choi MJ; Lee E
    Alcohol Alcohol; 2003; 38(2):135-41. PubMed ID: 12634260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Inhibitory Training Produce Reductions in Drinking? Evaluating the Influence of the Control Condition.
    Liu Q; Hu L; Smith JL; Mewton LR
    J Stud Alcohol Drugs; 2019 Jan; 80(1):96-101. PubMed ID: 30807280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of adding the community reinforcement approach to motivational enhancement therapy for adults aged 60 years and older with DSM-5 alcohol use disorder: a randomized controlled trial.
    Andersen K; Behrendt S; Bilberg R; Bogenschutz MP; Braun B; Buehringer G; Ekstrøm CT; Mejldal A; Petersen AH; Nielsen AS
    Addiction; 2020 Jan; 115(1):69-81. PubMed ID: 31454444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurophysiological correlates of alcohol-specific inhibition in alcohol use disorder and its association with craving and relapse.
    Batschelet HM; Tschuemperlin RM; Moggi F; Soravia LM; Koenig T; Pfeifer P; Roesner S; Keller A; Stein M
    Clin Neurophysiol; 2021 Jun; 132(6):1290-1301. PubMed ID: 33867254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Counselling for Alcohol Problems (CAP), a lay counsellor-delivered brief psychological treatment for harmful drinking in men, in primary care in India: a randomised controlled trial.
    Nadkarni A; Weobong B; Weiss HA; McCambridge J; Bhat B; Katti B; Murthy P; King M; McDaid D; Park AL; Wilson GT; Kirkwood B; Fairburn CG; Velleman R; Patel V
    Lancet; 2017 Jan; 389(10065):186-195. PubMed ID: 27988144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressants for the treatment of people with co-occurring depression and alcohol dependence.
    Agabio R; Trogu E; Pani PP
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008581. PubMed ID: 29688573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of inhibitory control training on alcohol consumption, implicit alcohol-related cognitions and brain electrical activity.
    Bowley C; Faricy C; Hegarty B; J Johnstone S; L Smith J; J Kelly P; A Rushby J
    Int J Psychophysiol; 2013 Sep; 89(3):342-8. PubMed ID: 23623953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of motivational enhancement therapy on alcohol use disorders in patients with chronic hepatitis C: a randomized controlled trial.
    Dieperink E; Fuller B; Isenhart C; McMaken K; Lenox R; Pocha C; Thuras P; Hauser P
    Addiction; 2014 Nov; 109(11):1869-77. PubMed ID: 25040898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive training in recently-abstinent individuals with alcohol use disorder improves emotional stroop performance: Evidence from a randomized pilot trial.
    Lewis B; Garcia CC; Price JL; Schweizer S; Nixon SJ
    Drug Alcohol Depend; 2022 Feb; 231():109239. PubMed ID: 34998253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural self-control training versus motivational enhancement therapy for individuals with alcohol use disorder with a goal of controlled drinking: A randomized controlled trial.
    Hammarberg SI; Wallhed Finn S; Rosendahl I; Andréasson S; Jayaram-Lindström N; Hammarberg A
    Addiction; 2024 Jan; 119(1):86-101. PubMed ID: 37658776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baclofen for alcohol use disorder.
    Minozzi S; Saulle R; Rösner S
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012557. PubMed ID: 30484285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.